EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 190 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $174,665 | -54.4% | 51,372 | -1.4% | 0.08% | -52.7% |
| Q2 2023 | $383,097 | -29.4% | 52,122 | -0.5% | 0.16% | -32.1% |
| Q1 2023 | $542,968 | +87334.5% | 52,410 | -0.3% | 0.24% | -17.1% |
| Q4 2022 | $621 | -100.0% | 52,590 | -24.5% | 0.29% | -60.4% |
| Q3 2022 | $1,462,000 | -33.3% | 69,651 | -1.3% | 0.74% | -29.6% |
| Q2 2022 | $2,191,000 | -24.4% | 70,588 | -0.1% | 1.05% | -11.8% |
| Q1 2022 | $2,900,000 | -9.7% | 70,625 | -4.4% | 1.19% | -4.6% |
| Q4 2021 | $3,211,000 | +5.0% | 73,875 | +21.0% | 1.25% | -9.4% |
| Q3 2021 | $3,057,000 | -15.3% | 61,050 | +6.5% | 1.38% | -14.7% |
| Q2 2021 | $3,609,000 | – | 57,300 | – | 1.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |